Amalia Luce Selected Research

Amalia Luce Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 01/2013
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 09/2013
5	Carcinogenesis 04/2021 - 07/2015
4	Melanoma (Melanoma, Malignant) 02/2020 - 09/2013
4	Carcinoma (Carcinomatosis) 02/2020 - 01/2014
2	Osteosarcoma (Osteogenic Sarcoma) 06/2022 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 02/2020
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 01/2014
2	Neoplasm Metastasis (Metastasis) 04/2016 - 09/2013
1	Circulating Neoplastic Cells 10/2021
1	Prostatic Neoplasms (Prostate Cancer) 10/2021
1	Inflammation (Inflammations) 04/2021
1	Colitis-Associated Neoplasms 04/2021
1	Colitis 04/2021
1	Squamous Cell Carcinoma of Head and Neck 05/2020
1	Laryngeal Neoplasms (Laryngeal Cancer) 05/2020
1	Kidney Neoplasms (Kidney Cancer) 02/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020
1	Breast Neoplasms (Breast Cancer) 10/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 11/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2014
1	Non-Muscle Invasive Bladder Neoplasms 06/2014
1	Adenomatous Polyps 01/2014
1	Brain Neoplasms (Brain Tumor) 09/2013
1	Adenocarcinoma 04/2013
1	Lung Neoplasms (Lung Cancer) 04/2013

Drug/Important Bio-Agent (IBA)

5	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2020
3	MicroRNAs (MicroRNA)IBA 04/2021 - 05/2020
3	urotensin IIIBA 01/2019 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 09/2020
2	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2014
2	NivolumabIBA 02/2020 - 01/2020
2	CytokinesIBA 01/2020 - 06/2019
2	Monoclonal AntibodiesIBA 01/2020 - 01/2020
2	Endocrine DisruptorsIBA 08/2016 - 07/2015
2	Environmental Pollutants (Pollutants, Environmental)IBA 08/2016 - 07/2015
2	Pharmaceutical PreparationsIBA 11/2014 - 01/2013
2	fotemustine (Muphoran)IBA 11/2014 - 09/2013
2	Small Interfering RNA (siRNA)IBA 06/2014 - 01/2014
1	Alkaline PhosphataseIBA 06/2022
1	Long Noncoding RNAIBA 01/2022
1	AndrogensIBA 10/2021
1	enzalutamideIBA 10/2021
1	Androgen Receptors (Androgen Receptor)IBA 10/2021
1	CeramidesIBA 01/2021
1	LipidsIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	polydatinIBA 01/2021
1	ProcalcitoninIBA 01/2021
1	SphingolipidsIBA 01/2021
1	Radiation-Sensitizing AgentsIBA 01/2021
1	afliberceptIBA 01/2021
1	Granzymes (Granzyme)IBA 10/2020
1	Nucleic AcidsIBA 09/2020
1	Biological ProductsIBA 05/2020
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020
1	lanreotide (Somatuline)FDA Link 01/2020
1	Everolimus FDA Link 01/2020
1	EpitopesIBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	HLA-B Antigens (HLA-B)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 06/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2019
1	PlatinumIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Cetuximab (Erbitux)FDA Link 01/2019
1	Liposomes (Liposome)IBA 01/2019
1	LigandsIBA 01/2019
1	Keratin-5 (Keratin 5)IBA 12/2014
1	Transferrin (beta 2 Transferrin)IBA 11/2014
1	Zoledronic Acid (Zometa)FDA Link 11/2014
1	Temozolomide (Temodar)FDA LinkGeneric 11/2014
1	Pen(5)-Trp(7)-Orn(8)- urotensin II (4-11)IBA 06/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	ErbB Receptors (EGF Receptor)IBA 04/2013
1	Anaplastic Lymphoma KinaseIBA 04/2013
1	Albumin-Bound Paclitaxel FDA Link 01/2013
1	130-nm albumin-bound paclitaxelIBA 01/2013

Therapy/Procedure

5	Radiotherapy 01/2021 - 04/2016
3	Therapeutics 01/2021 - 02/2020
1	Castration 10/2021
1	Immunotherapy 01/2020
1	Neoadjuvant Therapy 10/2019
1	Contraindications 01/2019
1	Laryngectomy 04/2016
1	Adjuvant Radiotherapy 07/2014
1	Drug Therapy (Chemotherapy) 09/2013